“…1, P1 and P2, respectively), and demonstrate a broad spectrum of action in the treatment of a variety of human neoplastic diseases, including ovarian, breast, lung, brain cancer and melanoma (Wani et al, 1971;Holms et al, 1991;Forastiere, 1993). Although some LC/MS/MS methods have been developed for detection of paclitaxel and docetaxel with LOQs at ng/mL levels using [M+H] + as the precursor ion (Basileo et al, 2003;Guo et al, 2003;Parise et al, 2003), these two compounds were shown in our work to produce somewhat unstable mass spectrometric detection due to the formation of multiple molecular adduct ions ( ). Furthermore, the calibration curve was nonlinear because of the formation of the [2M+Na] + adduct ion at high concentrations (Stefansson et al, 1996).…”